| Accession Number: | 0001127602-21-023884 |
| Date: | 2021-08-16 |
| Issuer: | APELLIS PHARMACEUTICALS, INC. (APLS) |
| Original Submission Date: |
MACHIELS ALEC
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM, MA 02451
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-16 | M | 2,500 | a | $2.67 | 672,044 | direct | ||
| COMMON STOCK | 2021-08-16 | S | 2,500 | d | $56.95 | 669,544 | direct | ||
| COMMON STOCK | 2021-08-16 | 0 | $0.00 | 1,950 | indirect | f2 |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 2.67 | 2021-08-16 | deemed execution date | M | 2,500 (d) | 2023-12-04 | common stock 2,500 | $2.67 | 137,529 | direct |
| ID | footnote |
|---|---|
| f1 | this is a scheduled exercise from 10b5-1 trading plan. |
| f2 | owned by spouse. |
| f3 | this option was granted on december 5, 2013 and fully vested. |
